Treatment with ledipasvir-sofosbuvir for hepatitis C resulting in improvement of lichen planus

Treatment with ledipasvir-sofosbuvir for hepatitis C resulting in improvement of lichen planus

Bibliographic Details
Main Authors:	Umer Ansari, BS, Lauren I. Henderson, MD, Geraldine Stott, MD, Karina Parr, MD
Format:	Article
Language:	English
Published:	Elsevier 2017-01-01
Series:	JAAD Case Reports
Subjects:	Harvoni hepatitis C ledipasvir-sofosbuvir lichen planus
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512616301515

Similar Items

Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection
by: Ahmed OA, et al.
Published: (2018-03-01)

Ledipasvir and sofosbuvir for treatment of post- renal transplant hepatitis C infection: A case report withreview of literature
by: R Jha, et al.
Published: (2016-01-01)

Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients
by: Mohammed A Babatin, et al.
Published: (2019-01-01)

Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis
by: Mohammad Saeid Rezaee-Zavareh, et al.
Published: (2017-03-01)

Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan
by: Hung-Chih Chiu, et al.
Published: (2021-03-01)

Successful Treatment of Hepatitis C Virus by Ledipasvir/Sofosbuvir in a Cirrhotic Patient with Sickle Cell Disease and Thalassemia Minor
by: Hassan Al Moussawi, et al.
Published: (2018-10-01)

Cardiac arrhythmia due to ledipasvir/sofosbuvir Iranian counterpart, commercially named as Ledibiox: A case report
by: Alireza Heidari Bakavoli, et al.
Published: (2020-09-01)

Early sofosbuvir-ledipasvir treatment for acute HCV infection induced severe immune thrombocytopenia – a case report
by: Vincent Alcazer, et al.
Published: (2018-12-01)

Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4
by: Nadia Marascio, et al.
Published: (2019-05-01)

Validated Reversed-Phase Liquid Chromatographic Method with Gradient Elution for Simultaneous Determination of the Antiviral Agents: Sofosbuvir, Ledipasvir, Daclatasvir, and Simeprevir in Their Dosage Forms
by: Essam Ezzeldin, et al.
Published: (2020-10-01)

Treatment of viral hepatitis C genotypes 1 and 2 by sofosbuvir and ledipasvir with or without ribavirin combination: A possible alternative to pangenotypic treatment in a low-income country?
by: Chantelli Iamblaudiot Razafindrazoto, et al.
Published: (2021-06-01)

Combination ledipasvir-sofosbuvir for the treatment of chronic hepatitis C virus infection: a review and clinical perspective
by: Nkuize M, et al.
Published: (2016-06-01)

Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study
by: Oidov Baatarkhuu, et al.
Published: (2021-01-01)

Delayed-Type Hypersensitivity Reaction to Red Tattoo Ink Triggered by Ledipasvir/Sofosbuvir for Hepatitis C: A Case Report
by: Meghan L. McPhie, et al.
Published: (2021-07-01)

Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study
by: Heidar Sharafi, et al.
Published: (2020-01-01)

Multicenter Experience using Ledipasvir/Sofosbuvir ± RBV to Treat HCV GT 1 Relapsers after Simeprevir and Sofosbuvir Treatment
by: Bashar Aqel, et al.
Published: (2018-09-01)

Efficacy and safety of ledipasvir/sofosbuvir for hepatitis C among drug users: a systematic review and meta-analysis
by: Xue Yang, et al.
Published: (2021-07-01)

Efficacy and Safety of Ledipasvir/Sofosbuvir with and without Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: a meta-analysis
by: Tingting Tao, et al.
Published: (2017-02-01)

Real-Life Experience with Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Virus Infection with Genotypes 1 and 4 in Children Aged 12 to 17 Years—Results of the POLAC Project
by: Maria Pokorska-Śpiewak, et al.
Published: (2021-09-01)

Simultaneous chromatographic analysis of Sofosbuvir/Ledipasvir in their combined dosage form: an application to green analytical chemistry
by: Ahmed Hemdan, et al.
Published: (2019-12-01)

Bilateral Linear Lichen Planus Pigmentosus Associated with Hepatitis C Virus Infection
by: Vasanop Vachiramon, et al.
Published: (2010-09-01)

Lichen Planus Pigmentosus Inversus: A Rare Subvariant of Lichen Planus Pigmentosus
by: Anne Guertler, et al.
Published: (2021-07-01)

Blaschkoid lichen planus: Throwing a “curve” in the nomenclature of linear lichen planus
by: Maressa C. Criscito, MD, et al.
Published: (2020-03-01)

Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries
by: Melissa J. Barber, et al.
Published: (2020-09-01)

Classical lichen planus and lichen planus pigmentosus inversus overlap with dermoscopic features
by: Şule Güngör, et al.
Published: (2014-01-01)

Ocular lichen planus: An unusual presentation, its treatment, and review of the literature
by: Mohannad Safadi, BS, et al.
Published: (2021-08-01)

Oral lichen planus and HCV infection
by: Jefferson R. Tenório, et al.
Published: (2021-08-01)

Blaschkoid lichen planus in an adult Kashmiri male: a rare presentation
by: Parvaiz Anwar Rather, et al.
Published: (2013-04-01)

Serum Levels of IL-22 in Patients with Oral Lichen Planus and Cutaneous Lichen Planus
by: Maryam Mardani, et al.
Published: (2020-12-01)

Childhood lichen planus: A series of 42 patients
by: Abhinav Kumar, et al.
Published: (2018-01-01)

Isolated Actinic Lichen Planus of the Lower Lip
by: Ellie Choi, et al.
Published: (2017-04-01)

Lichen planus pigmentosus: The controversial consensus
by: Aparajita Ghosh, et al.
Published: (2016-01-01)

Lichen planus follicularis tumidus
by: K. O. Chepushtanova, et al.
Published: (2019-05-01)

Glomerular filtration rate change during chronic hepatitis C treatment with Sofosbuvir/Ledipasvir in HCV/HIV Coinfected patients treated with Tenofovir and a boosted protease inhibitor: an observational prospective study
by: Cristina Aurora São Pedro Soeiro, et al.
Published: (2018-08-01)

Prevalence and characteristics of various types of lichen planus in the Moscow Region
by: Yu. V. Molochkova, et al.
Published: (2018-04-01)

Characterization of oral lichen planus in a subset of patients: A single-center experience
by: Azza F Alhelo, et al.
Published: (2020-01-01)

Lichen planus pigmentosus-inversus: A peculiar variant of lichen planus
by: Duru Tabanlıoğlu-Onan, et al.
Published: (2017-12-01)

Systemic tacrolimus in the treatment of recalcitrant mucosal lichen planus
by: Edward Chen, BA, et al.
Published: (2017-05-01)

Clinicopathologic features of Lichen planus patients in Mashhad-Iran
by: Mashayekhi Ghoyonlo V (MD), et al.
Published: (2010-09-01)

Bilateral linear lichen planus along the lines of Blaschko: Report of a rare case and brief review
by: Mohammadreza Mortazavi, et al.
Published: (2017-07-01)